Exome and Genome Sequencing and Parallels in Radiology: Searching for Patient-Centered Management of Incidental and Secondary Findings

被引:4
|
作者
Kang, Stella K. [1 ,2 ]
Spector-Bagdady, Kayte [3 ]
Caplan, Arthur L. [4 ]
Braithwaite, R. Scott [2 ,5 ]
机构
[1] NYU, Sch Med, Dept Radiol, New York, NY USA
[2] NYU, Sch Med, Dept Populat Hlth, New York, NY USA
[3] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI USA
[4] NYU, Dept Populat Hlth, Div Med Eth, Sch Med, New York, NY USA
[5] NYU, Sch Med, Dept Med, New York, NY USA
关键词
Incidental finding; genome sequencing; patient-centered care; WHITE PAPER; COMMITTEE II; PELVIC CT; AUTONOMY; RETURN; MRI;
D O I
10.1016/j.jacr.2016.06.050
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Incidental and secondary findings have become an important by-product of diagnostic testing, and their ramifications affect clinical care, research, and policy. Given parallels in the reporting and management of such findings on diagnostic imaging, radiologists may draw from ongoing discussions in medical genetics to rethink more patient-centered approaches to analogous clinical, ethical, and medicolegal dilemmas. Low-risk incidental findings in particular may be drivers of unnecessary testing, invasive procedures, and overtreatment, with associated financial, psychological, and clinical consequences. As radiologists act in patients' best interests by strengthening standardized guidelines on how each finding merits further diagnostic testing or treatment, perhaps the greatest challenge for producing such guidelines is for low-risk incidental findings, for which adverse consequences are unlikely but associated with substantial uncertainty because of the lack of strong evidence on which to base the recommendations. More uniform recommendations for managing low-risk radiologic incidental findings should therefore aim to provide reasonable options that apply across a spectrum of patient preferences. These will require evaluation through research and will ultimately influence the quality of care. Specific areas for exploration may include (1) better gauging of patient attitudes and preferences regarding low-risk incidental findings, (2) using patient preferences to inform more uniform recommendations for low-risk findings that apply across a spectrum of preferences and help guide shared decision making, and (3) when patients endorse a strong preference not to discover low-risk incidental findings, how it might be possible for professional standards to curtail their generation in specific circumstances.
引用
收藏
页码:1467 / 1472
页数:6
相关论文
共 12 条
  • [1] Patient-centered, value-based management of incidental findings in radiology
    Weckbach, Sabine
    Wielpuetz, Mark O.
    von Stackelberg, Oyunbileg
    RADIOLOGIE, 2023, 63 (09): : 657 - 664
  • [2] ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
    Green, Robert C.
    Berg, Jonathan S.
    Grody, Wayne W.
    Kalia, Sarah S.
    Korf, Bruce R.
    Martin, Christa L.
    McGuire, Amy L.
    Nussbaum, Robert L.
    O'Daniel, Julianne M.
    Ormond, Kelly E.
    Rehm, Heidi L.
    Watson, Michael S.
    Williams, Marc S.
    Biesecker, Leslie G.
    GENETICS IN MEDICINE, 2013, 15 (07) : 565 - 574
  • [3] On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing
    May, Thomas
    JOURNAL OF LAW MEDICINE & ETHICS, 2015, 43 (01) : 134 - 142
  • [4] Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing
    Godino, Lea
    Varesco, Liliana
    Bruno, William
    Bruzzone, Carla
    Battistuzzi, Linda
    Franiuk, Marzena
    Miccoli, Sara
    Bertonazzi, Benedetta
    Graziano, Claudio
    Seri, Marco
    Turchetti, Daniela
    JOURNAL OF GENETIC COUNSELING, 2021, 30 (03) : 665 - 675
  • [5] Patient-centered interventions to improve medication management and adherence: A qualitative review of research findings
    Kuntz, Jennifer L.
    Safford, Monika M.
    Singh, Jasvinder A.
    Phansalkar, Shobha
    Slight, Sarah P.
    Her, Qoua Liang
    Lapointe, Nancy Allen
    Mathews, Robin
    O'Brien, Emily
    Brinkman, William B.
    Hommel, Kevin
    Farmer, Kevin C.
    Klinger, Elissa
    Maniam, Nivethietha
    Sobko, Heather J.
    Bailey, Stacy C.
    Cho, Insook
    Rumptz, Maureen H.
    Vandermeer, Meredith L.
    Hornbrook, Mark C.
    PATIENT EDUCATION AND COUNSELING, 2014, 97 (03) : 310 - 326
  • [6] Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature
    Delanne, J.
    Nambot, S.
    Chassagne, A.
    Putois, O.
    Pelissier, A.
    Peyron, C.
    Gautier, E.
    Thevenon, J.
    Cretin, E.
    Bruel, A. L.
    Goussot, V.
    Ghiringhelli, F.
    Boidot, R.
    Mau-Them, F. Tran
    Philippe, C.
    Vitobello, A.
    Demougeot, L.
    Vernin, C.
    Lapointe, A. S.
    Bardou, M.
    Luu, M.
    Binquet, C.
    Lejeune, C.
    Joly, L.
    Juif, C.
    Baurand, A.
    Sawka, C.
    Bertolone, G.
    Duffourd, Y.
    Sanlaville, D.
    Pujol, P.
    Genevieve, D.
    Houdayer, F.
    Thauvin-Robinet, C.
    Faivre, L.
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2019, 62 (06)
  • [7] Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing
    Shahmirzadi, Layla
    Chao, Elizabeth C.
    Palmaer, Erika
    Parra, Melissa C.
    Tang, Sha
    Gonzalez, Kelly D. Farwell
    GENETICS IN MEDICINE, 2014, 16 (05) : 395 - 399
  • [8] Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
    Mackley, Michael P.
    Fletcher, Benjamin
    Parker, Michael
    Watkins, Hugh
    Ormondroyd, Elizabeth
    GENETICS IN MEDICINE, 2017, 19 (03) : 283 - 293
  • [9] Clinical genome sequencing and population preferences for information about 'incidental' findings D From medically actionable genes (MAGs) to patient actionable genes (PAGs)
    Ploug, Thomas
    Holm, Soren
    PLOS ONE, 2017, 12 (07):
  • [10] ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
    Miller, David T.
    Lee, Kristy
    Abul-Husn, Noura S.
    Amendola, Laura M.
    Brothers, Kyle
    Chung, Wendy K.
    Gollob, Michael H.
    Gordon, Adam S.
    Harrison, Steven M.
    Hershberger, Ray E.
    Klein, Teri E.
    Richards, C. Sue
    Stewart, Douglas R.
    Martin, C. L.
    GENETICS IN MEDICINE, 2023, 25 (08)